Deutsche Bank AG boosted its position in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 37.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 51,816 shares of the semiconductor company's stock after acquiring an additional 14,228 shares during the period. Deutsche Bank AG owned 0.16% of Silicon Laboratories worth $6,437,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also added to or reduced their stakes in SLAB. Jones Financial Companies Lllp raised its position in shares of Silicon Laboratories by 44.5% during the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 69 shares during the period. Headlands Technologies LLC bought a new stake in Silicon Laboratories during the 4th quarter valued at $70,000. Venturi Wealth Management LLC raised its holdings in Silicon Laboratories by 207.0% during the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock worth $98,000 after buying an additional 530 shares during the last quarter. Asset Management One Co. Ltd. bought a new position in shares of Silicon Laboratories in the fourth quarter valued at $117,000. Finally, KBC Group NV lifted its stake in shares of Silicon Laboratories by 42.1% in the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock valued at $159,000 after buying an additional 379 shares in the last quarter.
Insider Buying and Selling at Silicon Laboratories
In other Silicon Laboratories news, SVP Robert J. Conrad sold 4,029 shares of the business's stock in a transaction on Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $528,604.80. Following the sale, the senior vice president now directly owns 25,380 shares in the company, valued at $3,329,856. The trade was a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Christy Wyatt sold 546 shares of Silicon Laboratories stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $104.45, for a total value of $57,029.70. Following the completion of the sale, the director now directly owns 8,492 shares of the company's stock, valued at approximately $886,989.40. This trade represents a 6.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,626 shares of company stock worth $1,509,319 over the last three months. 1.60% of the stock is currently owned by insiders.
Silicon Laboratories Trading Down 2.8%
Shares of SLAB traded down $3.64 on Wednesday, reaching $124.86. 294,823 shares of the company's stock traded hands, compared to its average volume of 337,115. The stock's 50 day simple moving average is $109.00 and its two-hundred day simple moving average is $121.41. The stock has a market cap of $4.07 billion, a PE ratio of -21.02 and a beta of 1.36. Silicon Laboratories Inc. has a 52-week low of $82.82 and a 52-week high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. The company had revenue of $177.71 million for the quarter, compared to analysts' expectations of $177.48 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business's revenue for the quarter was up 67.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.92) EPS. Analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on SLAB. Benchmark restated a "buy" rating and issued a $160.00 target price on shares of Silicon Laboratories in a report on Wednesday, May 14th. Stifel Nicolaus lowered their price objective on Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. KeyCorp lifted their target price on Silicon Laboratories from $115.00 to $160.00 and gave the company an "overweight" rating in a research report on Wednesday, January 22nd. StockNews.com upgraded Silicon Laboratories from a "sell" rating to a "hold" rating in a report on Wednesday, May 14th. Finally, Susquehanna raised their price objective on Silicon Laboratories from $100.00 to $110.00 and gave the company a "neutral" rating in a research note on Wednesday, May 14th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $126.50.
Read Our Latest Report on SLAB
Silicon Laboratories Company Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report